Literature DB >> 14908561

The duration of untreated or inadequately treated Plasmodium falciparum infections in the human host.

D E EYLES, M D YOUNG.   

Abstract

Entities:  

Keywords:  FEVER THERAPY; NEUROSYPHILIS/therapy; PLASMODIUM FALCIPARUM

Mesh：

Year:  1951        PMID： 14908561

Source DB:  PubMed          Journal:  J Natl Malar Soc


× No keyword cloud information.
  31 in total

1.  A biologic basis for integrated malaria control.

Authors:  F Ellis McKenzie; J Kevin Baird; John C Beier; Altaf A Lal; William H Bossert
Journal:  Am J Trop Med Hyg       Date:  2002-12       Impact factor: 2.345

2.  OBSERVATIONS ON THE LONGEVITY OF PLASMODIUM FALCIPARUM: WITH SPECIAL REFERENCE TO FINDINGS IN MAURITIUS.

Authors:  J VERDRAGER
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

3.  Benefits of using multiple first-line therapies against malaria.

Authors:  Maciej F Boni; David L Smith; Ramanan Laxminarayan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-09       Impact factor: 11.205

4.  The entomological inoculation rate and Plasmodium falciparum infection in African children.

Authors:  D L Smith; J Dushoff; R W Snow; S I Hay
Journal:  Nature       Date:  2005-11-24       Impact factor: 49.962

5.  Cross-reactive immune responses as primary drivers of malaria chronicity.

Authors:  Eili Y Klein; Andrea L Graham; Manuel Llinás; Simon Levin
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

6.  Competition for red blood cells can enhance Plasmodium vivax parasitemia in mixed-species malaria infections.

Authors:  Philip G McQueen; F Ellis McKenzie
Journal:  Am J Trop Med Hyg       Date:  2006-07       Impact factor: 2.345

Review 7.  Measuring changes in Plasmodium falciparum transmission: precision, accuracy and costs of metrics.

Authors:  Lucy S Tusting; Teun Bousema; David L Smith; Chris Drakeley
Journal:  Adv Parasitol       Date:  2014       Impact factor: 3.870

8.  The impact of heterogeneous transmission on the establishment and spread of antimalarial drug resistance.

Authors:  Eili Y Klein
Journal:  J Theor Biol       Date:  2013-09-25       Impact factor: 2.691

9.  Clinical Implications of Asymptomatic Plasmodium falciparum Infections in Malawi.

Authors:  Andrea G Buchwald; Alick Sixpence; Mabvuto Chimenya; Milius Damson; John D Sorkin; Mark L Wilson; Karl Seydel; Sarah Hochman; Don P Mathanga; Terrie E Taylor; Miriam K Laufer
Journal:  Clin Infect Dis       Date:  2019-01-01       Impact factor: 9.079

10.  Determinants of MDA impact and designing MDAs towards malaria elimination.

Authors:  Bo Gao; Sompob Saralamba; Yoel Lubell; Lisa J White; Arjen M Dondorp; Ricardo Aguas
Journal:  Elife       Date:  2020-04-15       Impact factor: 8.140
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.